vs

Side-by-side financial comparison of SCOTTS MIRACLE-GRO CO (SMG) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

SCOTTS MIRACLE-GRO CO is the larger business by last-quarter revenue ($1.5B vs $220.8M, roughly 6.6× UNIVERSAL TECHNICAL INSTITUTE INC). SCOTTS MIRACLE-GRO CO runs the higher net margin — 16.3% vs 5.8%, a 10.5% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs -16.9%). Over the past eight quarters, SCOTTS MIRACLE-GRO CO's revenue compounded faster (10.2% CAGR vs 9.5%).

The Scotts Miracle-Gro Company is an American multinational corporation headquartered in Marysville, Ohio, where O.M. Scott began selling lawn seed in 1868. The company manufactures and sells consumer lawn, garden and pest control products, as well as soilless indoor gardening equipment. In the U.S., the company manufactures Scotts, Miracle-Gro and Ortho brands. It also markets and distributes the herbicide Roundup in the U.S. and several international markets including China.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

SMG vs UTI — Head-to-Head

Bigger by revenue
SMG
SMG
6.6× larger
SMG
$1.5B
$220.8M
UTI
Growing faster (revenue YoY)
UTI
UTI
+26.5% gap
UTI
9.6%
-16.9%
SMG
Higher net margin
SMG
SMG
10.5% more per $
SMG
16.3%
5.8%
UTI
Faster 2-yr revenue CAGR
SMG
SMG
Annualised
SMG
10.2%
9.5%
UTI

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
SMG
SMG
UTI
UTI
Revenue
$1.5B
$220.8M
Net Profit
$238.6M
$12.8M
Gross Margin
41.8%
Operating Margin
27.5%
7.1%
Net Margin
16.3%
5.8%
Revenue YoY
-16.9%
9.6%
Net Profit YoY
61.2%
-42.1%
EPS (diluted)
$-2.00
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SMG
SMG
UTI
UTI
Q1 26
$1.5B
Q4 25
$354.4M
$220.8M
Q3 25
$387.3M
$222.4M
Q2 25
$1.2B
$204.3M
Q1 25
$1.4B
$207.4M
Q4 24
$416.8M
$201.4M
Q3 24
$414.7M
$196.4M
Q2 24
$1.2B
$177.5M
Net Profit
SMG
SMG
UTI
UTI
Q1 26
$238.6M
Q4 25
$-125.0M
$12.8M
Q3 25
$18.8M
Q2 25
$149.1M
$10.7M
Q1 25
$217.5M
$11.4M
Q4 24
$-69.5M
$22.2M
Q3 24
$18.8M
Q2 24
$132.1M
$5.0M
Gross Margin
SMG
SMG
UTI
UTI
Q1 26
41.8%
Q4 25
25.0%
Q3 25
6.1%
Q2 25
31.8%
Q1 25
38.6%
Q4 24
22.7%
Q3 24
-7.1%
Q2 24
29.5%
Operating Margin
SMG
SMG
UTI
UTI
Q1 26
27.5%
Q4 25
-6.2%
7.1%
Q3 25
-38.8%
11.2%
Q2 25
18.1%
6.9%
Q1 25
24.3%
8.1%
Q4 24
-12.2%
13.6%
Q3 24
-52.1%
13.3%
Q2 24
16.6%
4.2%
Net Margin
SMG
SMG
UTI
UTI
Q1 26
16.3%
Q4 25
-35.3%
5.8%
Q3 25
8.4%
Q2 25
12.6%
5.2%
Q1 25
15.3%
5.5%
Q4 24
-16.7%
11.0%
Q3 24
9.6%
Q2 24
11.0%
2.8%
EPS (diluted)
SMG
SMG
UTI
UTI
Q1 26
$-2.00
Q4 25
$-2.16
$0.23
Q3 25
$-2.58
$0.33
Q2 25
$2.54
$0.19
Q1 25
$3.72
$0.21
Q4 24
$-1.21
$0.40
Q3 24
$-4.21
$0.35
Q2 24
$2.28
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SMG
SMG
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$6.2M
$162.8M
Total DebtLower is stronger
$2.3B
$101.4M
Stockholders' EquityBook value
$335.9M
Total Assets
$3.4B
$834.0M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SMG
SMG
UTI
UTI
Q1 26
$6.2M
Q4 25
$8.3M
$162.8M
Q3 25
$36.6M
$169.1M
Q2 25
$51.1M
$70.7M
Q1 25
$16.9M
$96.0M
Q4 24
$9.8M
$172.0M
Q3 24
$71.6M
$161.9M
Q2 24
$279.9M
$115.5M
Total Debt
SMG
SMG
UTI
UTI
Q1 26
$2.3B
Q4 25
$101.4M
Q3 25
$2.1B
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$2.2B
$125.7M
Q2 24
$137.3M
Stockholders' Equity
SMG
SMG
UTI
UTI
Q1 26
Q4 25
$-500.6M
$335.9M
Q3 25
$-357.5M
$328.1M
Q2 25
$-170.9M
$306.8M
Q1 25
$-290.1M
$293.9M
Q4 24
$-479.5M
$280.0M
Q3 24
$-390.6M
$260.2M
Q2 24
$-146.2M
$239.4M
Total Assets
SMG
SMG
UTI
UTI
Q1 26
$3.4B
Q4 25
$3.0B
$834.0M
Q3 25
$2.7B
$826.1M
Q2 25
$3.1B
$740.8M
Q1 25
$3.5B
$720.4M
Q4 24
$3.2B
$753.8M
Q3 24
$2.9B
$744.6M
Q2 24
$3.5B
$706.0M
Debt / Equity
SMG
SMG
UTI
UTI
Q1 26
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SMG
SMG
UTI
UTI
Operating Cash FlowLast quarter
$3.1M
Free Cash FlowOCF − Capex
$-19.2M
FCF MarginFCF / Revenue
-8.7%
Capex IntensityCapex / Revenue
10.1%
Cash ConversionOCF / Net Profit
0.24×
TTM Free Cash FlowTrailing 4 quarters
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SMG
SMG
UTI
UTI
Q1 26
Q4 25
$-370.4M
$3.1M
Q3 25
$174.1M
$57.1M
Q2 25
$454.4M
$18.1M
Q1 25
$188.1M
$-789.0K
Q4 24
$-445.3M
$23.0M
Q3 24
$118.5M
$67.5M
Q2 24
$588.0M
$10.0M
Free Cash Flow
SMG
SMG
UTI
UTI
Q1 26
Q4 25
$-390.4M
$-19.2M
Q3 25
$131.2M
$40.6M
Q2 25
$437.5M
$6.8M
Q1 25
$179.8M
$-11.7M
Q4 24
$-474.6M
$19.6M
Q3 24
$101.9M
$60.0M
Q2 24
$574.8M
$3.0M
FCF Margin
SMG
SMG
UTI
UTI
Q1 26
Q4 25
-110.2%
-8.7%
Q3 25
33.9%
18.3%
Q2 25
36.8%
3.4%
Q1 25
12.7%
-5.7%
Q4 24
-113.9%
9.7%
Q3 24
24.6%
30.6%
Q2 24
47.8%
1.7%
Capex Intensity
SMG
SMG
UTI
UTI
Q1 26
Q4 25
5.6%
10.1%
Q3 25
11.1%
7.4%
Q2 25
1.4%
5.5%
Q1 25
0.6%
5.3%
Q4 24
7.0%
1.7%
Q3 24
4.0%
3.8%
Q2 24
1.1%
4.0%
Cash Conversion
SMG
SMG
UTI
UTI
Q1 26
Q4 25
0.24×
Q3 25
3.04×
Q2 25
3.05×
1.69×
Q1 25
0.86×
-0.07×
Q4 24
1.04×
Q3 24
3.58×
Q2 24
4.45×
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SMG
SMG

Segment breakdown not available.

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons